EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies

Lisa Crowe, Morven C Brown, Jan Lecouturier, Alastair Greystoke, Desy Nuryunarsih, Ben Rimmer, Andy Bojke, Rona Bojke, James Richardson, Mary Wells, Ezinne Ezeala, Louise Carter und 2 weitere

Journal of Cancer Survivorship · 2026

DOI: 10.1007/s11764-025-01787-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Survivorship, 2026. Verfasst von Lisa Crowe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Claremont Road, Newcastle Upon Tyne, NE1 7RU, UK. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Needs Assessment, Health Services Needs and Demand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macmillan Cancer Support, National Institute for Health and Care Research (NIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Develop an instrument to assess unmet needs in cancer patients using immuno-, biological and precision (IBP) therapies.

Methods

Development followed COSMIN guidance. Instruments to assess unmet needs of advanced cancer patients were identified, and quality and content were evaluated in a systematic review (Phase 1). Semi-structured interviews with patients utilising IBP therapies ( n = 31) and healthcare professionals ( n = 22) explored supportive care needs (Phase 2). Phase 3 selected a base instrument to adapt, generated new items and iteratively refined these through six meetings involving professionals ( n = 8) and public and patient involvement representatives ( n = 9) and patient cognitive interviews ( n = 16). Phase 4 piloted the new instrument ( n = 50 patients).

Results

Twenty-four instruments were identified; none was developed for patients utilising IBP therapies (Phase 1). Ten domains of unmet needs were identified from the interview data (Phase 2). SCNS-SF34 was selected as the base instrument. Informed by interview data, an “add-on module” (SCNS-TARGET) was developed for patients utilising IBP therapies comprising 25 questions (psychological domain, 7 items; information, 6; healthcare, 5; economic, 3; role, 2; physical, 1; social, 1; Phase 3). Levels of missingness were low; reliability varied across questions, and, on average, patients reported 7.40 (standard deviation = 8.43) unmet needs on SCNS-TARGET (Phase 4).

Conclusions

SCNS-TARGET is designed for use alongside SCNS-SF34 to assess unmet needs in those using IBP therapies. Content and face validity have been established. Implications for Cancer Survivors SCNS-TARGET can help researchers and healthcare professionals determine unmet needs and inform requirements for new services and interventions, among patients using IBP therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPrecision MedicineNeeds AssessmentHealth Services Needs and DemandImmunotherapyHumansFemaleMaleMiddle AgedAgedSurveys and QuestionnairesQuality of LifeAdult

Stichwörter der Autor:innen

Advanced cancerBiological therapiesImmunotherapyUnmet needs

Autor:innen und Institutionen

  • Population Health Sciences Institute, Newcastle University, Ridley 1 Building, Claremont Road, Newcastle Upon Tyne, NE1 7RU, UK.
  • Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne, UK.
  • Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • PPI Contributors, Newcastle Upon Tyne, UK.
  • Nursing Directorate, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Surgery and Cancer, Imperial College London, London, UK.

Förderung

  • Macmillan Cancer Support
  • National Institute for Health and Care Research (NIHR)

Zitieren

APA

Crowe, L., Brown, M. C., Lecouturier, J., Greystoke, A., Nuryunarsih, D., Rimmer, B., Bojke, A., Bojke, R., Richardson, J., Wells, M., Ezeala, E., Carter, L., Todd, A., & Sharp, L. (2026). Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-025-01787-4

Vancouver

Crowe L, Brown MC, Lecouturier J, Greystoke A, Nuryunarsih D, Rimmer B, et al. Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies. Journal of Cancer Survivorship. 2026. doi:10.1007/s11764-025-01787-4

BibTeX
@article{Crowe2026,
  author = {Crowe, Lisa and Brown, Morven C and Lecouturier, Jan and Greystoke, Alastair and Nuryunarsih, Desy and Rimmer, Ben and Bojke, Andy and Bojke, Rona and Richardson, James and Wells, Mary and Ezeala, Ezinne and Carter, Louise and Todd, Adam and Sharp, Linda},
  title = {Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies},
  journal = {Journal of Cancer Survivorship},
  year = {2026},
  doi = {10.1007/s11764-025-01787-4}
}
Kostenlos starten →